MY137801A - Tablet for oral administration comprising 2-[(4-methoxy-3-methyl)-2-pyridinyl]methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole - Google Patents

Tablet for oral administration comprising 2-[(4-methoxy-3-methyl)-2-pyridinyl]methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole

Info

Publication number
MY137801A
MY137801A MYPI20022067A MY137801A MY 137801 A MY137801 A MY 137801A MY PI20022067 A MYPI20022067 A MY PI20022067A MY 137801 A MY137801 A MY 137801A
Authority
MY
Malaysia
Prior art keywords
tablet
methylsulfinyl
pyrrol
benzimidazole
pyridinyl
Prior art date
Application number
Inventor
Dong-Yeun Kim
Dong-Woo Park
Hee-Jun Kim
Original Assignee
Il Yang Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Il Yang Pharm Co Ltd filed Critical Il Yang Pharm Co Ltd
Priority to MYPI20022067 priority Critical patent/MY137801A/en
Publication of MY137801A publication Critical patent/MY137801A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

THE PRESENT INVENTION PROVIDES AN TABLET FOR ORAL ADMINISTRATION PREPARE BY MIXING THE ACTIVE INGREDIENT, 2-[(4-METHOXY-3-METHYL)-2-PYRIDINYL] METHYLSULFINYL-5-(1H-PYRROL-1-YL)-1H-BENZIMIDAZOLE, ALKALI COMPOUND AS A STABILIZER, AND A PHARMACEUTICALLY ACCEPTABLE ADDITIVE, TABLETING THE MIXTURE TO MAKE A NAKED TABLET, FIRSTLY COATING THE NAKED TABLET WITH A FILM FORMING MATERIAL, AND SECONDLY COATING THE TABLET WITH AN ENTERIC COATING MATERIAL.
MYPI20022067 2002-06-04 2002-06-04 Tablet for oral administration comprising 2-[(4-methoxy-3-methyl)-2-pyridinyl]methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole MY137801A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20022067 MY137801A (en) 2002-06-04 2002-06-04 Tablet for oral administration comprising 2-[(4-methoxy-3-methyl)-2-pyridinyl]methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20022067 MY137801A (en) 2002-06-04 2002-06-04 Tablet for oral administration comprising 2-[(4-methoxy-3-methyl)-2-pyridinyl]methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole

Publications (1)

Publication Number Publication Date
MY137801A true MY137801A (en) 2009-03-31

Family

ID=45699472

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20022067 MY137801A (en) 2002-06-04 2002-06-04 Tablet for oral administration comprising 2-[(4-methoxy-3-methyl)-2-pyridinyl]methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole

Country Status (1)

Country Link
MY (1) MY137801A (en)

Similar Documents

Publication Publication Date Title
BR0306870A (en) Oral pharmaceutical composition and method for preparing the same
PT2038290E (en) Modulators of toll-like receptor 7
NO20084065L (en) Quick-release paracetamol tablets
CY1124914T1 (en) SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING AN INTEGRATION INHIBITOR
UA96449C2 (en) Stable laquinimod preparations
WO2006011159A3 (en) Stabilized pharmaceutical composition containing rabeprazole sodium with improved bioavailability
TW200806282A (en) Solid dosage formulations
TW200517106A (en) Sustained release pharmaceutical compositions
CY1113462T1 (en) DOSAGE FORM CONTENTS Pantoprazole as an Active Ingredient
WO2008142572A3 (en) Controlled release tablet formulation containing magnesium aluminometasilicate
IL164440A0 (en) New pharmaceutical composition containing fibanserin polymorph a
NO20013060L (en) Controlled release pharmaceutical preparation with tilidine mesylate as active ingredient
SI1105105T1 (en) Oral administration form for pyridin-2-ylmethylsulfinyl-1h-benzimidazoles
EA200500213A1 (en) DISPENSABLE TABLETS FOR ORAL APPOINTMENT
WO2005117895A8 (en) Compositions comprising meloxicam
WO2008101173A3 (en) Biodegradable compositions and materials
MXPA04003346A (en) Flashmelt oral dosage formulation.
MXPA05010613A (en) Parenteral formulation of mycophenolic acid, a salt or prodrug thereof.
EP3978027A4 (en) Physiologically active substance bound to biotin moiety, and composition for oral administration including same
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
WO2007121471A3 (en) Dialkyl ether delivery agents
MY137801A (en) Tablet for oral administration comprising 2-[(4-methoxy-3-methyl)-2-pyridinyl]methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole
DE602005008128D1 (en) Cytisine-containing drug
WO2007011958A3 (en) Intraoral dosage forms of glucagon
WO2010018593A3 (en) Gastric acid resistant benzimidazole multiple unit tablet composition